Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Defne A Amado

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 11, 2021
Gene therapy for ALS: A reviewDefne A Amado, Beverly L Davidson
Muscle & Nerve|April 26, 2024
A single ALS center experience with clinical use of sodium phenylbutyrate-taurursodiolColin Quinn, Michael Baer, Defne A Amado, et al.
BMC Neuroscience|March 10, 2004
Pattern of distribution and cycling of SLOB, Slowpoke channel binding protein, in DrosophilaAngela M Jaramillo, Xiangzhong Zheng, Yi Zhou, et al.
Biology|February 23, 2024
The Importance of Offering Exome or Genome Sequencing in Adult Neuromuscular ClinicsLaynie Dratch, Tanya M Bardakjian, Kelsey Johnson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 19, 2018
AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated ToxicityDefne A Amado, Julianne M Rieders, Fortunay Diatta, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Scouring the human Hsp70 network uncovers diverse chaperone safeguards buffering TDP-43 toxicityEdward M Barbieri, Miriam Linsenmeier, Katherine R Whiteman, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALSDefne A Amado, Ashley B Robbins, Alicia R Smith, et al.
Research Square|August 23, 2023
Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrumTing Shen, Jacob W Vogel, Jeffrey Duda, et al.
Translational Neurodegeneration|December 8, 2023
Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrumTing Shen, Jacob W Vogel, Jeffrey Duda, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Digital markers of motor speech impairments in natural speech of patients with ALS-FTD spectrum disordersSanjana Shellikeri, Sunghye Cho, Sharon Ash, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 11, 2021
Gene therapy for ALS: A reviewDefne A Amado, Beverly L Davidson
Muscle & Nerve|April 26, 2024
A single ALS center experience with clinical use of sodium phenylbutyrate-taurursodiolColin Quinn, Michael Baer, Defne A Amado, et al.
BMC Neuroscience|March 10, 2004
Pattern of distribution and cycling of SLOB, Slowpoke channel binding protein, in DrosophilaAngela M Jaramillo, Xiangzhong Zheng, Yi Zhou, et al.
Biology|February 23, 2024
The Importance of Offering Exome or Genome Sequencing in Adult Neuromuscular ClinicsLaynie Dratch, Tanya M Bardakjian, Kelsey Johnson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 19, 2018
AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated ToxicityDefne A Amado, Julianne M Rieders, Fortunay Diatta, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Scouring the human Hsp70 network uncovers diverse chaperone safeguards buffering TDP-43 toxicityEdward M Barbieri, Miriam Linsenmeier, Katherine R Whiteman, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALSDefne A Amado, Ashley B Robbins, Alicia R Smith, et al.
Research Square|August 23, 2023
Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrumTing Shen, Jacob W Vogel, Jeffrey Duda, et al.
Translational Neurodegeneration|December 8, 2023
Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrumTing Shen, Jacob W Vogel, Jeffrey Duda, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Digital markers of motor speech impairments in natural speech of patients with ALS-FTD spectrum disordersSanjana Shellikeri, Sunghye Cho, Sharon Ash, et al.
Pageof 2